Boston Scientific (BSX): Director bought ~$100K
Cheryl Pegus, Director at Boston Scientific, bought ~$100K of Boston Scientific shares.
- ~$100K
- Approx. value · 1,770 sh @ $56.49
- 1,770
- Holds after · shares reported
- Traded
- May 20, 2026
- Filed
- May 21, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 4, 2025Federal contract · $601K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $601K obligated to date
- Dec 23, 2025Federal contract · $493K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $493K obligated to date
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Apr 22, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- Apr 30, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
- May 6, 20265% stakeFMR LLC reported a passive stake (13G) of 5.1%
- May 11, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- May 19, 2026Insider · First insider buy since Dec 2024Director purchased ~$125K of BSX shares in the open market
- May 19, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- May 20, 2026 · this disclosureInsider · 3 insiders in a week, 6th time since 2006Director purchased ~$100K of BSX shares in the open market
What came next
- May 20, 2026Insider · 2 peopleInsiders: 2 purchases (~$329K)
- May 29, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Jun 4, 2026CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Jun 5, 2026Congress · 1 personMembers of Congress: 1 purchase, 1 sale
- Jul 16, 2026Federal contract · $608K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $608K obligated to date
- Jul 21, 2026Company filing · Form 8-K · RestructuringAnnounced job cuts, closures or a restructuring“On July 21, 2026, the Board of Directors of Boston Scientific Corporation (the “Company”) approved a new global restructuring program (the “2026 Restructuring Plan”).”
- Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
- Jul 31, 2026InsiderDirector purchased ~$227K of BSX shares in the open market
- Aug 3, 2026Insider · 2 peopleInsiders: 2 purchases (~$9.1M)
- Aug 4, 2026Insider · 3 insiders in a week, 7th time since 2006Director purchased ~$6.8K of BSX shares in the open market
- Aug 5, 2026Insider · 3 insiders in a week, 7th time since 2006Director purchased ~$100K of BSX shares in the open market
- Aug 6, 20265% stakeFMR LLC reported a passive stake (13G) of 3.1%
- Aug 18, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Aug 25, 2026Insider · 13 days before an 8-KDirector purchased ~$100K of BSX shares in the open market
- Sep 7, 2026Company filing · Form 8-K · Cyber incidentReported a cybersecurity incident“As previously disclosed in a Current Report on Form 8-K filed on August 26, 2026 with the Securities and Exchange Commission, on August 25, 2026, Boston Scientific Corporation (the “ Company ”) identified a cybersecurity incident that affected certain of its information technology systems and resulted in a global disruption to the Company’s operations.”
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/FATHOM/021/BERN/1RO/155; Material Number: M001195650
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/J/1RO/130; Material Number: M001195270
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/027/BERN/1RO/130; Material Number: M001195440
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/FATHOM/027/BERN/1RO/155; Material Number: M001195750
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/TRANSEND/021/BERN/1RO/130; Material Number: M001195840
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Boston Scientific
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.
How this filing works
Explore the data
Common questions
Which Boston Scientific (BSX) insider traded, and how much?
Cheryl Pegus, Director at Boston Scientific, bought ~$100K of Boston Scientific shares. 1,770 shares at $56.49, open market.
When did it happen, and when was it made public?
Traded: May 20, 2026. Filed: May 21, 2026. That is 1 day between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Boston Scientific recently?
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.
Does this mean BSX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Boston Scientific
- SEC Form 13F-HRNov 16, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
Everything OQRO holds on this company is on its BSX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
